- Investing Ideas
- /
- Chinese Healthcare Strong Past Earnings Growth, P/E Ratio Below 20
Chinese Healthcare Strong Past Earnings Growth, P/E Ratio Below 20
Results
4
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
4 companies
Tibet Rhodiola Pharmaceutical Holding
Market Cap: CN¥11.6b
Tibet Rhodiola Pharmaceutical Holding Co.
600211
CN¥35.94
7D
1.8%
1Y
0.4%
HangzhouS MedTech
Market Cap: CN¥5.6b
Engages in the research, development, production, sale, and service of endoscopic surgery equipment and accessories in China.
688581
CN¥69.00
7D
-4.7%
1Y
23.7%
Innovita Biological Technology
Market Cap: CN¥4.9b
Engages in the research and development, manufacturing, marketing, and sales of POCT rapid diagnostic products.
688253
CN¥35.90
7D
4.8%
1Y
-0.3%
Well Lead Medical
Market Cap: CN¥3.6b
Engages in the development, production, and sale of medical devices in anaesthesia, urology, endourology, respiratory, pain management, and hemodialysis areas worldwide.
603309
CN¥12.13
7D
3.1%
1Y
3.6%